John D Quisel, Director, Chief Executive Officer, on June 18, 2026, sold 34,000 shares in Disc Medicine (IRON) for $2,387,296. Following the Form 4 filing with the SEC, Quisel has control over a total of 226,064 common shares of the company, with 226,064 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1816736/000119312526279779/xslF345X05/ownership.xml